DINESH

Narayana Hrudalaya

Industry: Healthcare
Latest CMP 1,833
Today's Change ▲ 0.09%
52-Week High / Low 2,080 | 1,602
Price Date: 14-Aug-2026
Recommendation Buy
Target Price 2,633
Expected Upside 19.9%
Forecast Horizon 2 Years
Historical CAGR 19.4%
1,000 Invested 06-Jan-2016
Today's Value 6,558
Investment Period 11 Years

Stock Snapshot

Post Results Return
-6.6%
Mild Negative Re-rating
1-Year Target Price
2,169
2-Year Target Price
2,633
52-Week High / Low
2,080 / 1,602
20-Day Return
-9.5%
Market Cap (Cr.)
37,451
Current PE
48.8
P/BV Ratio
8.2
Dividend Yield
0.3%
Industry PE
57.2

Price Performance

Basis of our Recommendation

Narayana Hrudayalaya's management is focused on long-term value creation through digital transformation and capacity expansion, with a significant capex commitment of INR 30 billion aimed at adding 1,535 beds in India. This strategic direction supports Vista's forecast of moderate revenue growth, driven by strong operational performance in the domestic market, despite facing margin pressures from international operations and ongoing restructuring efforts. The company's emphasis on integrated care and high-end clinical services positions it well within a growing healthcare sector, although execution risks remain a concern. Industry dynamics, including stable pricing power and a shift towards corporate healthcare, further bolster the outlook. Over the next 12-24 months, key opportunities include the commissioning of new facilities and the optimization of supply chains, while watchpoints include potential delays in project timelines and the performance of the insurance segment. Overall, Vista anticipates an expected upside of approximately 18.5%, with a target price of INR 2,171.68 for the next 12 months, reflecting a balanced view of growth potential and existing challenges

👍 Why We Like This Stock

  • Significant capex commitment of INR 30 billion to expand capacity and enhance service offerings
  • Strong operational performance in India, with a 40% YoY EBITDA growth driven by high-end procedures
  • Focus on integrated care and digital transformation aligns with industry trends towards corporate healthcare

Things To Watch Out For

  • Margin pressures from international operations and ongoing restructuring efforts may impact profitability
  • Execution risks related to complex corporate restructuring and project delays could hinder growth timelines
  • The insurance segment remains a drag on profitability, with volatility affecting overall performance

Key Parameters

Balance Sheet Strength
Stable Financial Structure
Market Share
Stable
Industry Outlook
Stable
Analyst View
Strong Buy
Dividend History
Consistent
FII Holdings
Reducing

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 4,890 5,483 7,896 9,833 12,209
Profit Before Tax (Cr.) 883 933 1,019 940 1,357
PBT Margin 18.1% 17.0% 1290.5% 9.6% 11.1%
Net Profit (Cr.) 750 805 834 772 1,114
Earnings Per Share 36.7 39.4 40.8 37.8 54.5

Analyst Recommendations

Broker Recommendation Target Price Date
Choice Equity ▲ Buy 2,500 03-Jun-2026
HSBC ▼ Sell 1,630 21-Apr-2026
ICICI Securities ► Hold 2,245 27-May-2026
Kotak Securities ► Add 2,100 27-May-2026
Prabhudas Liladhar ▲ Buy 2,350 04-Aug-2026
Consensus Recommendation ▲ Strong Buy
Consensus Target 2,298
Coverage 5 Analysts
Analysts' Viewpoint
Narayana Hrudayalaya's growth is underpinned by plans to add 1,535 beds through expansions in India, supported by a robust 40% YoY EBITDA growth in its domestic business. However, challenges persist with international operations, notably in the UK and Cayman, due to environmental impacts and seasonal weaknesses. Delays in projects in Rajarhat and Bangalore could affect timelines. Key catalysts include the commissioning of the Southwest Bengaluru hospital and successful Cayman insurance renewals.

Company Overview

Show Company Profile

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.